MCID: GTT002
MIFTS: 30

Guttate Psoriasis

Categories: Gastrointestinal diseases, Rare diseases, Skin diseases

Aliases & Classifications for Guttate Psoriasis

MalaCards integrated aliases for Guttate Psoriasis:

Name: Guttate Psoriasis 20 70 32
Psoriasis Guttate 20

Classifications:



External Ids:

ICD10 32 L40.4
UMLS 70 C0343052

Summaries for Guttate Psoriasis

GARD : 20 Guttate psoriasis is a skin condition in which small, red, and scaly teardrop-shaped spots appear on the arms, legs, and middle of the body. It is a relatively uncommon form of psoriasis. The condition often develops very suddenly, and is usually triggered by an infection (e.g., strep throat, bacteria infection, upper respiratory infections or other viral infections). Other triggers include injury to the skin, including cuts, burns, and insect bites, certain malarial and heart medications, stress, sunburn, and excessive alcohol consumption. Treatment depends on the severity of the symptoms, ranging from at-home over the counter remedies to medicines that suppress the body's immune system to sunlight and phototherapy.

MalaCards based summary : Guttate Psoriasis, also known as psoriasis guttate, is related to psoriasis 1 and psoriasis 4. An important gene associated with Guttate Psoriasis is HLA-C (Major Histocompatibility Complex, Class I, C), and among its related pathways/superpathways are Innate Immune System and Measles. Affiliated tissues include t cells and neutrophil.

Wikipedia : 73 Guttate psoriasis (also known as eruptive psoriasis) is a type of psoriasis that presents as small... more...

Related Diseases for Guttate Psoriasis

Diseases related to Guttate Psoriasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 90)
# Related Disease Score Top Affiliating Genes
1 psoriasis 1 30.4 HLA-C CDSN
2 psoriasis 4 30.2 HLA-C CDSN
3 psoriasis 29.8 NOD2 ITGAL IFNG HLA-C CDSN CAMP
4 bacterial infectious disease 29.5 NOD2 IFNG CAMP
5 lichen planus 29.5 ITGAL IFNG
6 disease by infectious agent 29.5 NOD2 IFNG CAMP
7 skin disease 29.3 ITGAL IFNG HLA-C CDSN CAMP
8 dermatitis, atopic 29.2 NOD2 IFNG CDSN CAMP
9 pustulosis of palm and sole 11.0
10 exanthem 10.4
11 tonsillitis 10.3
12 pharyngitis 10.3
13 dermatitis 10.3
14 pityriasis rosea 10.3
15 kawasaki disease 10.2
16 scarlet fever 10.2
17 pustular psoriasis 10.2
18 psoriasis 5 10.2 HLA-C CDSN
19 birdshot chorioretinopathy 10.1 KIR2DS1 HLA-C
20 glomerulonephritis 10.1
21 chickenpox 10.1
22 crohn's disease 10.1
23 pityriasis lichenoides 10.1
24 pityriasis lichenoides chronica 10.1
25 autoimmune gastritis 10.0 IFNG HLA-C
26 idiopathic bronchiectasis 10.0 IFNG HLA-C
27 syphilis 10.0 IFNG HLA-C
28 autoimmune disease of skin and connective tissue 10.0 IFNG HLA-C
29 vogt-koyanagi-harada disease 10.0 IFNG HLA-C
30 graft-versus-host disease 10.0 IFNG HLA-C
31 gastrointestinal tuberculosis 10.0 NOD2 IFNG
32 intestinal tuberculosis 10.0 NOD2 IFNG
33 vitiligo-associated multiple autoimmune disease susceptibility 6 10.0
34 vitiligo-associated multiple autoimmune disease susceptibility 1 10.0
35 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 10.0
36 psoriasis 8 10.0
37 psoriasis 12 10.0
38 hand, foot and mouth disease 10.0
39 sarcoma 10.0
40 balanoposthitis 10.0
41 balanitis 10.0
42 exostosis 10.0
43 vulvovaginitis 10.0
44 arthropathy 10.0
45 mouth disease 10.0
46 spindle cell sarcoma 10.0
47 conjunctivitis 10.0
48 influenza 10.0
49 rosacea 10.0
50 parapsoriasis 10.0

Graphical network of the top 20 diseases related to Guttate Psoriasis:



Diseases related to Guttate Psoriasis

Symptoms & Phenotypes for Guttate Psoriasis

Drugs & Therapeutics for Guttate Psoriasis

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Immunogenetic Profiling of Guselkumab for the Treatment of Plaque and Guttate Psoriasis Not yet recruiting NCT04645355 Phase 4 Guselkumab

Search NIH Clinical Center for Guttate Psoriasis

Genetic Tests for Guttate Psoriasis

Anatomical Context for Guttate Psoriasis

MalaCards organs/tissues related to Guttate Psoriasis:

40
T Cells, Neutrophil

Publications for Guttate Psoriasis

Articles related to Guttate Psoriasis:

(show top 50) (show all 269)
# Title Authors PMID Year
1
Durable remissions of guttate psoriasis following short courses of IL-17 inhibitors. 61
33650164 2021
2
Evaluation of expression of Toll-Like Receptors 7 and 9, proliferation, and cytoskeletal biomarkers in plaque and guttate psoriasis: A pilot morphological study. 61
33666385 2021
3
Interplay between Humoral and CLA+ T Cell Response against Candida albicans in Psoriasis. 61
33546306 2021
4
Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older. 61
33485646 2021
5
Dermoscopic characterization of guttate psoriasis, pityriasis rosea, and pityriasis lichenoides chronica in dark skin phototypes: An observational study. 61
33277950 2021
6
Dermoscopy Differentiates Guttate Psoriasis from a Mimicker-Pityriasis Rosea. 61
33614216 2021
7
HLA-Cw1 and Psoriasis. 61
33460021 2021
8
Immune checkpoint-mediated psoriasis: A multicenter European study of 115 patients from the European Network for Cutaneous Adverse Event to Oncologic Drugs (ENCADO) group. 61
33279646 2020
9
Histological and immunohistopathological differentiation between guttate psoriasis and pityriasis rosea. 61
33020906 2020
10
A Case of Lichen Planus Masquerading as Guttate Psoriasis. 61
33269137 2020
11
Guttate psoriasis secondary to COVID-19. 61
32784237 2020
12
Histone Deacetylase 1 and Sirtuin 1 Expression in Psoriatic Skin: A Comparison between Guttate and Plaque Psoriasis. 61
32825671 2020
13
Specific IgA and CLA+ T-Cell IL-17 Response to Streptococcus pyogenes in Psoriasis. 61
31972247 2020
14
Guttate Psoriasis. 61
32562412 2020
15
Seasonality and global public interest in psoriasis: an infodemiology study. 61
31511319 2020
16
Anagen Effluvium after Methotrexate: An Idiosyncratic Reaction. 61
32684684 2020
17
A review of antibiotics and psoriasis: induction, exacerbation, and amelioration. 61
31498683 2019
18
Extrarenal Immune-Mediated Disorders Linked with Acute Poststreptococcal Glomerulonephritis: a Systematic Review. 61
31392657 2019
19
Guttate psoriasis following presumed coxsackievirus A. 61
31774885 2019
20
At First Glance: Psoriatic Response to Transdermal Nicotine Patch Application. 61
32083060 2019
21
S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2. 61
31538732 2019
22
Acute onset of psoriatic spondyloarthritis as a new manifestation of post-streptococcal reactive arthritis: a case series. 61
31332690 2019
23
A case of guttate psoriasis during treatment with dupilumab. 61
31215726 2019
24
S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 1. 61
31437363 2019
25
Resolution of Guttate Psoriasis Plaques After One-time Administration of Guselkumab 61
31424714 2019
26
Linear Lichen Planus in the Setting of Annual Vaccination. 61
30215756 2019
27
WITHDRAWN: Interventions for guttate psoriasis. 61
30964200 2019
28
Non-antistreptococcal interventions for acute guttate psoriasis or an acute guttate flare of chronic psoriasis. 61
30958563 2019
29
Antistreptococcal interventions for guttate and chronic plaque psoriasis. 61
30835819 2019
30
WITHDRAWN: Antistreptococcal interventions for guttate and chronic plaque psoriasis. 61
30839103 2019
31
Low Dose Naltrexone in Dermatology 61
30909326 2019
32
Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials. 61
29874367 2018
33
The distinct role and regulatory mechanism of IL-17 and IFN-γ in the initiation and development of plaque vs guttate psoriasis. 61
30072243 2018
34
Juvenile psoriasis: an epidemiological study of 69 cases. 61
27374182 2018
35
Childhood psoriasis: a survey among pediatricians in Italy. 61
27706115 2018
36
Compounded Low-dose Naltrexone for the Treatment of Guttate Psoriasis: A Case Report. 61
30021181 2018
37
Association of the novel susceptible locus rs9266150 with clinical features of psoriasis vulgaris in the Chinese Han population. 61
29630754 2018
38
Is there a correlation of serum and tissue T helper-1 and -2 cytokine profiles with psoriasis activity and severity? A cross-sectional study. 61
29491194 2018
39
HLA-Cw6 and psoriasis. 61
29072309 2018
40
Epidemiological survey of patients with psoriasis in Matsumoto city, Nagano Prefecture, Japan. 61
29047148 2018
41
Epidemiological survey from 2009 to 2012 of psoriatic patients in Japanese Society for Psoriasis Research. 61
29115687 2018
42
Microbe-Dependent Induction of IL-9 by CLA+ T Cells in Psoriasis and Relationship with IL-17A. 61
29054600 2018
43
Complete resolution of guttate psoriasis after tonsillectomy. 61
29554398 2018
44
A secondary syphilis rash with scaly target lesions. 61
29410787 2018
45
Group A streptococcal pharyngitis: Immune responses involved in bacterial clearance and GAS-associated immunopathologies. 61
28951419 2018
46
Anti-Programmed Cell Death-1-Induced Plaque and Guttate Psoriasis. 61
29527039 2018
47
Epidemiology and Clinical Features of Adult Patients with Psoriasis in Malaysia: 10-Year Review from the Malaysian Psoriasis Registry (2007-2016). 61
29849578 2018
48
CLA+ T Cell Response to Microbes in Psoriasis. 61
30013558 2018
49
Skin Manifestations of Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, and Spondyloarthritides. 61
28752373 2017
50
Ustekinumab-induced remission of recalcitrant guttate psoriasis: A case series. 61
28932788 2017

Variations for Guttate Psoriasis

Expression for Guttate Psoriasis

Search GEO for disease gene expression data for Guttate Psoriasis.

Pathways for Guttate Psoriasis

GO Terms for Guttate Psoriasis

Biological processes related to Guttate Psoriasis according to GeneCards Suite gene sharing:

(show all 13)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.67 KIR2DS1 IFNG HLA-C
2 neutrophil degranulation GO:0043312 9.65 ITGAL HLA-C CAMP
3 positive regulation of interleukin-6 production GO:0032755 9.52 NOD2 IFNG
4 positive regulation of tumor necrosis factor production GO:0032760 9.51 NOD2 IFNG
5 interferon-gamma-mediated signaling pathway GO:0060333 9.46 IFNG HLA-C
6 innate immune response GO:0045087 9.46 NOD2 KIR2DS1 HLA-C CAMP
7 positive regulation of interleukin-1 beta production GO:0032731 9.43 NOD2 IFNG
8 regulation of immune response GO:0050776 9.43 KIR2DS1 ITGAL HLA-C
9 positive regulation of phagocytosis GO:0050766 9.4 NOD2 IFNG
10 positive regulation of interleukin-12 production GO:0032735 9.37 NOD2 IFNG
11 innate immune response in mucosa GO:0002227 9.32 NOD2 CAMP
12 positive regulation of nitric-oxide synthase biosynthetic process GO:0051770 8.96 NOD2 IFNG
13 cellular response to peptidoglycan GO:0071224 8.62 CAMP NOD2

Sources for Guttate Psoriasis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
Content
Loading form....